Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11685749 C26-linked rapamycin analogs as mTOR inhibitors

Patent 11685749 was granted and assigned to Revolution Medicines, Inc. on June, 2023 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 23 Oct, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12121522 Methods of treating cancer with an mTOR inhibitor
0
Edits on 31 Jul, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 31 Jul, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
0
Edits on 28 Jun, 2023
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 28 Jun, 2023
Edits made to:
Infobox (+26 properties)
Article (+232 characters)
‌

 US Patent 11685749 C26-linked rapamycin analogs as mTOR inhibitors

Article

The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.

Infobox
Is a
Patent
Patent
0
Patent Applicant
‌
Revolution Medicines, Inc.
0
Current Assignee
‌
Revolution Medicines, Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
116857490
Date of Patent
June 27, 2023
0
Patent Application Number
170861690
Date Filed
October 30, 2020
0
Patent Citations
‌
US Patent 7160867 Rapamycin carbohydrate derivatives
0
‌
US Patent 7241771 Oxepane isomer of 42-O-(2-hydroxy)ethyl-rapamycin
0
‌
US Patent 7429596 1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
0
‌
US Patent 8101602 Pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mTOR inhibitors
0
‌
US Patent 8410131 Cancer treatment
0
‌
US Patent 8785454 Heterocyclic compounds and uses thereof
0
‌
US Patent 8980899 Methods of inhibiting Ire1
0
‌
US Patent 9321772 Substituted pyrazolo[3,4-D]pyrimidines and uses thereof
0
‌
US Patent 9358229 JAK PI3K/mTOR combination therapy
0
‌
US Patent 9512125 Substituted pyrazolo[3.4-D] pyrimidines as anti-inflammatory agents
0
‌
US Patent 9603891 Peptide compound for inhibiting restenosis and promoting re-endothelialization and method for preparing the same
0
‌
US Patent 9629843 MTOR modulators and uses thereof
0
‌
US Patent 10117945 mTORC1 inhibitors
0
‌
US Patent 10160767 Rapamycin derivative, and a preparation method, pharmaceutical composition and use thereof
0
‌
US Patent 10980889 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
0
‌
US Patent 11364300 C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
0
Patent Primary Examiner
‌
Kahsay Habte
0
CPC Code
‌
C07D 519/00
0

Find more entities like US Patent 11685749 C26-linked rapamycin analogs as mTOR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo